Tharimmune Stock Market Value
| THAR Stock | 2.26 0.04 1.74% |
| Symbol | Tharimmune |
Tharimmune Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tharimmune. If investors know Tharimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tharimmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 61.01 | Return On Assets (1.65) | Return On Equity (4.55) |
The market value of Tharimmune is measured differently than its book value, which is the value of Tharimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Tharimmune's value that differs from its market value or its book value, called intrinsic value, which is Tharimmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tharimmune's market value can be influenced by many factors that don't directly affect Tharimmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tharimmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tharimmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tharimmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tharimmune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tharimmune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tharimmune.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Tharimmune on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Tharimmune or generate 0.0% return on investment in Tharimmune over 30 days. Tharimmune is related to or competes with Bright Minds, HP, Intel, Chevron Corp, Coca Cola, Travelers Companies, and Johnson Johnson. Tharimmune is entity of United States. It is traded as Stock on NASDAQ exchange. More
Tharimmune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tharimmune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tharimmune upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.51 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 85.88 | |||
| Value At Risk | (10.70) | |||
| Potential Upside | 9.22 |
Tharimmune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tharimmune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tharimmune's standard deviation. In reality, there are many statistical measures that can use Tharimmune historical prices to predict the future Tharimmune's volatility.| Risk Adjusted Performance | 0.0172 | |||
| Jensen Alpha | 0.049 | |||
| Total Risk Alpha | (1.56) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | 0.2378 |
Tharimmune Backtested Returns
Currently, Tharimmune is extremely dangerous. Tharimmune owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0142, which indicates the firm had a 0.0142% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Tharimmune, which you can use to evaluate the volatility of the company. Please validate Tharimmune's Coefficient Of Variation of 9623.15, semi deviation of 5.36, and Risk Adjusted Performance of 0.0172 to confirm if the risk estimate we provide is consistent with the expected return of 0.15%. Tharimmune has a performance score of 1 on a scale of 0 to 100. The entity has a beta of 0.42, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tharimmune's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tharimmune is expected to be smaller as well. Tharimmune right now has a risk of 10.73%. Please validate Tharimmune value at risk, and the relationship between the jensen alpha and skewness , to decide if Tharimmune will be following its existing price patterns.
Auto-correlation | 0.09 |
Virtually no predictability
Tharimmune has virtually no predictability. Overlapping area represents the amount of predictability between Tharimmune time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tharimmune price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Tharimmune price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | -0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Tharimmune lagged returns against current returns
Autocorrelation, which is Tharimmune stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tharimmune's stock expected returns. We can calculate the autocorrelation of Tharimmune returns to help us make a trade decision. For example, suppose you find that Tharimmune has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tharimmune regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tharimmune stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tharimmune stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tharimmune stock over time.
Current vs Lagged Prices |
| Timeline |
Tharimmune Lagged Returns
When evaluating Tharimmune's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tharimmune stock have on its future price. Tharimmune autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tharimmune autocorrelation shows the relationship between Tharimmune stock current value and its past values and can show if there is a momentum factor associated with investing in Tharimmune.
Regressed Prices |
| Timeline |
Pair Trading with Tharimmune
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tharimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tharimmune will appreciate offsetting losses from the drop in the long position's value.Moving together with Tharimmune Stock
Moving against Tharimmune Stock
| 0.62 | OPT | Opthea | PairCorr |
| 0.47 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.46 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.36 | ESLAW | Estrella Immunopharma | PairCorr |
The ability to find closely correlated positions to Tharimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tharimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tharimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tharimmune to buy it.
The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tharimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tharimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tharimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Tharimmune Stock Analysis
When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.